Phase 2 Anaplastic Thyroid Cancer Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
Efficacy of Pembrolizumab and Lenvatinib in Patients With Anaplastic Thyroid Cancer
Anaplastic Thyroid Cancer
Saint Petersburg State University, Russia20 enrolled1 locationNCT06374602
Recruiting
Phase 2
Sacituzumab govitEcan in THYroid Cancers
Anaplastic Thyroid CancerDifferentiated Thyroid Cancer
Grupo Espanol de Tumores Neuroendocrinos42 enrolled11 locationsNCT06235216
Recruiting
Phase 2
Study of the Rechallenge Concept in Patients With BRAF-positive Anaplastic Thyroid Cancer After Progression on Anti-BRAF Therapy
Anaplastic Thyroid Cancer
Saint Petersburg State University, Russia10 enrolled1 locationNCT06362694
Recruiting
Phase 2
NEO- and Adjuvant Targeted Therapy in Braf-mutated Anaplastic Cancer of the Thyroid (NEO-ATACT Study)
Anaplastic Thyroid Cancer
Leiden University Medical Center20 enrolled1 locationNCT06079333